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i. Summary / Abstract 
The Wilms’ tumour suppressor gene 1 (Wt1) is critically involved in a number of 
developmental processes in vertebrates, including cell differentiation, control of the 
epithelial/mesenchymal phenotype, proliferation and apoptosis. Wt1 proteins act as 
transcriptional and post-transcriptional regulators, in mRNA splicing and in protein-
protein interactions. Furthermore, Wt1 is involved in adult tissue homeostasis, kidney 
function and cancer. For these reasons, Wt1 function has been extensively studied in a 
number of animal models to establish its spatiotemporal expression pattern and the 
developmental fate of the cells expressing this gene. In this chapter, we review the 
developmental anatomy of Wt1, collecting information about its dynamic expression in 
mesothelium, kidney, gonads, cardiovascular system, spleen, nervous system, lung and 
liver. We also describe the adult expression of Wt1 in kidney podocytes, gonads, 
mesothelia, visceral adipose tissue and a small fraction of bone marrow cells. We have 
reviewed the available animal models for Wt1-expressing cell lineage analysis, including 
direct Wt1 expression reporters and systems for permanent Wt1 lineage tracing, based 
on constitutive or inducible Cre recombinase expression under control of a Wt1 
promoter. Finally we provide a number of laboratory protocols to be used with these 
animal models in order to assess reporter expression.   
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Developmental anatomy of Wt1 
 
The Wilms’ tumour suppressor gene 1 (Wt1) is well known for its dynamic expression 
pattern during embryonic development, both in mouse and human. The gene gives rise to at 
least 24 protein isoforms in human, that are involved in regulation of expression of target 
genes acting in tissue development, growth, differentiation, and apoptosis. Target gene 
expression is frequently regulated through binding to co-regulators. Furthermore, Wt1 
proteins also act as post-transcriptional regulators in mRNA splicing and in protein-protein 
interaction (1).  
In this chapter, we first give a short overview of the distribution of Wt1 expression at gene 
and/or protein level during development in mice and other animal models, and describe the 
adult expression of Wt1. We then review the murine models available for the study of Wt1 
function, and provide protocols that include the use of some of these models, with special 
emphasis on Wt1-expressing cell lineage tracing (in short: Wt1 lineage tracing). 
 
Mesothelium: 
The mesothelium is a simple epithelium that lines the coelomic cavities and the organs that 
develop within these cavities. It forms from the lateral mesoderm at around E9 in the 
mouse embryo. By this time Wt1 transcripts start to be detected in the parietal coelomic 
lining, and over the heart, intestine and urogenital ridge (2). Expression of Wt1 protein 
appears first over the urogenital ridge at E9.5, but between E10.5 and E11.5 Wt1 protein is 
present in the mesothelial layers of the parietal coelomic linings, over the heart, intestine, 
lungs and liver, and also in the septum transversum and developing diaphragm (3-7). Wt1 is 
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also found in many submesothelial mesenchymal cells in the parietal layers of the coelom at 
later stages of development (8).  
 
Kidney: 
Expression analysis of the murine Wt1 gene in the developing kidney by in situ hybridisation 
and immunohistological analysis revealed that Wt1 mRNA/Wt1 protein is expressed in the 
urogenital ridge from E9, the pro- and mesonephric tissues from E10, and the metanephric 
mesenchyme (MM) from E12 (9,10). The functional postnatal kidney develops from two 
tissues that have their origin in the intermediate mesoderm, the metanephric mesenchyme 
and the ureteric bud (UB). Reciprocal induction events between MM and UB lead to the 
formation of the functional kidney. This involves several rounds of induction and branching 
events, involving MM condensation into the mesenchymal cap around the UB, and a 
subsequent differentiation of condensed cap mesenchyme via mesenchymal-to-epithelial 
transition (MET) into epithelial cells forming the nephron. Expression of Wt1 in metanephric 
structures is highly dynamic with highest levels of expression in the condensing cap 
mesenchyme, comma- and s-shaped body of the developing nephrons, and finally remaining 
restricted to the podocytes of the glomeruli (11-13). This was confirmed in transgenic mice 
expressing LacZ under control of YAC fragments that harboured the human WT1 gene locus 
including flanking regions of 470 or 280kb (14). Wt1 expression is not found in the UB. 
Specifically, Wt1 is intimately involved in the regulation of the early steps of nephron 
formation and the maintenance of the glomeruli, through interactions with a range of 
nephrogenic and renal proteins. Wt1 regulates kidney development from early stages 
leading to complete renal agenesis in loss of Wt1 mutants through apoptosis of the 
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mesonephric tubules and the metanephric mesenchyme, resulting in failure to induce 
ureteric bud outgrowth (15). Apoptosis of renal progenitors in absence of Wt1 has recently 
been related with downregulation of fibroblast growth factor and induction of BMP/pSMAD 
signalling, and this apoptosis can be rescued by recombinant FGFs or inhibition of pSMAD 
signalling (16). Analysis of subsequent stages of kidney development, which is precluded 
due to metanephric apoptosis in the Wt1 null mutants, has been performed using kidney 
organoid culture in combination with siRNA approaches (17), and conditional inactivation of 
Wt1 in vivo (18). These studies showed that Wt1 controls MET to allow formation of renal 
vesicles and subsequent stages towards nephron formation from MM, through control of 
Wnt4 expression. Wnt4 has been identified as a crucial regulator of MET during nephron 
formation (19,20). Furthermore, a specific role for Wt1 in the control of Wnt4 expression 
had been described since Wt1 expression precedes that of Wnt4, Wt1 can control Wnt4 
expression in vitro, and Wnt4 expression is lost in the embryonic kidney mesenchyme when 
Wt1 is inactivated (18, 21,22).  
At later stages, Wt1 protein controls formation of the podocytes and their homeostasis 
through transcriptional regulation of Pax2, Nephrin and Podocalyxin (13, 23-26).  
Wt1 also regulates expression of Nestin, an intermediate filament protein, in the glomeruli, 
although the significance of Nestin expression in the kidney is not well understood (27). 
Conditional deletion of Wt1 in embryonic kidneys using a Nestin-Cre model leads to a failure 
in MET and nephron formation (18). 
Using ChIP-PCR to identify Wt1 target sites in vivo, a recent systemic study demonstrated 
that a range of factors important for kidney development are transcriptional targets of Wt1, 
including Bmp7 and Sall1 (28). Taken together, recent studies in the developing kidney have 
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shown that Wt1 is a key regulator of a range of molecular pathways that lead to the 
formation of functional nephrons from the metanephric mesenchyme. 
 
Gonads: 
Gonads develop from the urogenital ridge, initially as indifferent primordia, but later they 
specify into testis and ovaries. They start to arise at around E11 from the mesonephros, the 
embryonic kidney that forms only transiently, and the overlying coelomic mesothelium. The 
coelomic mesothelial cells contribute to gonad formation by migrating into the gonadal 
ridge, forming the primary sex cords and later giving rise to the Sertoli cells (male) or 
granulosa cells (female) (29, 30). In situ hybridisation and immunohistochemical studies 
have shown that Wt1 is expressed in the mesonephros and the overlying coelomic 
epithelium from around E10, but as the urogenital ridges thickens during gonad formation, 
Wt1 is strongly expressed in the mesenchymal component (12, 13).  
Development into male or female gonads and genital organs is regulated by Sry expression, 
leading to testes formation and differentiation of the Wolffian ducts into seminal vesicles, 
epididymis and vas deferens in the male, or ovary formation and the emergence of the 
oviducts, Fallopian tubes, uterus and upper vagina from the Müllerian ducts in the female. 
However, most components of the testis arise from mesonephric cells migrating into the 
gonad, including peritubular and vascular endothelial cells, while the Leydig cells are formed 
in several waves from primary mesonephric and mesonephric-derived cells (31-33). One can 
speculate that since Wt1 is expressed in the gonadal anlagen from early on, most gonadal 
cells have their origin in cells originally expressing Wt1. 
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Testis: A complex hierarchical cascade of transcription and signalling factors controls the 
formation and maintenance of the male gonads. Wt1 is involved in this cascade at several 
levels since Wt1 expression is required for the survival of the early gonadal anlagen (34). A 
range of studies have shown that Wt1 is an important regulator of sex determination by 
controlling the expression of the Sry gene (34-39). Loss of function studies have 
demonstrated that Wt1 regulates the expression of steroidogenic factor 1 (Sf1) in the 
indifferent gonad (40). In addition, molecular and in vitro data indicate that Wt1 acts in 
concert with Sf1 to regulate the expression of the Müllerian inhibiting substance (MIS, also 
called anti-Müllerian hormone, AMH) (41), and it probably indirectly activates Dax1 during 
early gonadal development (42).  
Using a mouse model for testis-specific conditional ablation of Wt1, Vicky Huff and 
collaborators showed that Wt1 is required for the formation and maintenance of the 
seminiferous tubules, Sertoli cells and germ cells in the testicular cords (43). Specifically, 
proteins expressed in Sertoli cells including Sox8, Sox9 and MIS were lost when Wt1 
function was abolished. Importantly, loss of Wt1 in the testes leads to β-catenin 
accumulation which in turn results in testicular cord disruption (44). Further evidence for a 
role of Wt1 in testicular cord and Sertoli cell maintenance and germ cell survival stems from 
the finding that testicular cord integrity is associated with expression of Col4a1 and Col4a2 
as these collagens are downregulated in the testes of mice with testis-specific loss of Wt1 
(45). Using an siRNA approach and transgenic mice expressing dominant negative Wt1, 
similar results were reported, supporting an essential role for Wt1 in Sertoli cell and germ 
cell integrity and survival (46). 
 
Wilm and Munoz-Chapuli 
8 
 
Ovary: During female gonad development, Wt1 is expressed in stromal cells, granulosa cells 
and the overlying coelomic mesothelium of the ovary (10). Specifically, granulosa cells of the 
primordial, primary and secondary follicles express Wt1 during ovary development, and 
expression is maintained throughout adult life (47), suggesting that Wt1 is involved in 
folliculogenesis.  
 
Germ cells: Wt1 is expressed in germ cells when they start converting from primary germ 
cells to gonadal germ cells, beginning at embryonic day E11.5. Chimera experimentation has 
shown that loss of Wt1 in ES cells leads to their exclusion from the germ cell lineage, 
suggesting that Wt1 is involved in germ cells proliferation, maturation or survival (48). 
 
Heart and blood vessels: 
Wt1 expression in the heart is predominantly, but not exclusively, associated with epicardial 
development. The earliest expression of Wt1 during cardiac morphogenesis is detected in 
mouse embryos at E9.5 in the proepicardium, which is the epicardial primordium; 
subsequently, Wt1 expression continues during the epicardial covering of the heart (2, 49). 
Wt1 expression is maintained in the epicardial-derived mesenchymal cells (EPDC) which 
delaminate from the epicardium and invade first the subepicardial space, and then the 
myocardium. This expression is progressively downregulated as EPDC differentiate and 
contribute to the vascular and connective tissue of the heart.  
The role played by Wt1 in the developing epicardium seems to be critical, since conditional 
Wt1 loss of function in this tissue leads to impaired generation of EPDC, abnormal coronary 
morphogenesis and thinning of the myocardium, resulting in embryonic lethality (50). The 
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mechanism by which Wt1 acts in the epicardium is not completely understood, but results 
from recent studies suggest that the balance between Snail and E-cadherin activity (50) and 
the canonical -catenin pathway (51) serve as main downstream effectors of Wt1 in 
regulating epicardial to mesenchymal transition. Additionally, recent data indicate that in 
the epicardium Wt1 regulates the transcriptional activation of Raldh2, which represents the 
main retinoic acid synthesising enzyme in mesodermal tissues (52). It had been previously 
established that cross-talk between epicardium and myocardium, facilitating development 
of both components, is dependent on retinoic acid signaling (53, 54).  
Other genes activated by Wt1 in the epicardium include the neurotrophin receptor TrkB (55) 
and 4 integrin, required to maintain epicardial adhesion to the myocardium (56). Wt1 
regulates expression of the erythropoietin receptor (57) in hematopoietic cells and its ligand 
erythropoietin in in vitro assays (58). Since the erythropoietin signaling system also acts in 
the epicardium and its failure causes myocardial thinning (59), Wt1 may also be involved 
through this pathway in epicardial-myocardial interaction, thus supporting development 
and differentiation of both tissues. Finally, an unsuspected role of Wt1 in the developing 
epicardium is the regulation of the expression of some chemokines. Specifically, Wt1 down-
regulates Ccl5 and Cxcl10, two chemokines that inhibit EPDC migration and myocardial 
proliferation. This role is performed through increasing of the levels of Irf7 (60). 
In summary, in the epicardium Wt1 activates a set of genes related with epicardial adhesion, 
epithelial-mesenchymal transition and migration. Thus, Wt1 represents a key gene for 
epicardial development and function.  
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Wt1 expression has also been found in non-epicardial derived, cardiac cells. A few cells 
expressing Wt1 are already present in the endocardium and possibly in the myocardium of 
E9.5 embryos (61).  
Lineage tracing studies of Wt1-expressing cells using Cre-LoxP technology have shed further 
light onto the role of Wt1 during cardiovascular development and function. Importantly, 
these studies have shown that the fate of Wt1-expressing cells in the heart is clearly related 
to coronary vascularization and the formation of cardiac connective tissue. Specifically, Wt1-
lineage studies have confirmed an extensive contribution to coronary smooth muscle and 
cardiac fibroblasts (62). EPDC-derived Wt1-expressing cells have also been shown to 
contribute to the lateral atrioventricular cushions where they differentiate into fibroblastic 
cells of the valves (63). However, contribution of Wt1-expressing cells to coronary 
endothelium has been more controversial. Using different lineage tracing approaches, it was 
shown that the proportion of coronary endothelial cells originating from Wt1-expressing 
cells comprises less than 15% (3, 62). Recent data (Cano et al., submitted) demonstrate a 
large, but not complete, overlap between the Wt1 lineage and a bona fide epicardial-
derived lineage characterized by the activation of a Gata4 enhancer in the septum 
transversum and proepicardium. These epicardial-derived cells contribute to a minor, but 
significant fraction of the coronary endothelium (about 20% of all the endothelial cells), at 
least during embryonic life and early postnatal stages. This agrees with recent findings 
reporting that the endocardium is a major contributor to the coronary endothelium (64, 65). 
Wagner and colleagues showed that Wt1 is expressed in the coronary endothelium of late 
gestation mouse embryos, while Wt1-/- embryos that survive to close to term, reveal a 
dramatic lack in coronary vasculature (55). In addition, the group could identify the 
neurotrophin receptor TrkB as a downstream target of Wt1 in the coronary endothelium 
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(55), and argued that loss of the coronary vasculature in Wt1 mutant embryos was directly 
linked to down-regulation of TrkB expression. 
Furthermore, using in vitro experiments, Wt1 was shown to bind to the VEGF promoter and 
regulate its expression (66, 67). The intermediate filament and progenitor marker Nestin has 
also been shown to be downstream of Wt1 in the developing coronary vasculature (27), and 
to be co-expressed the vasa vasorum of human tissue samples (68.The finding that Wt1 
regulates VE-cadherin expression in vitro and in vivo since VE-cadherin expression is reduced 
in the liver and hearts of Wt1 mutant embryos (69), corroborates the hypothesis that Wt1 is 
important for the regulation of blood vessel formation. 
Lineage tracing studies have also added to controversy around the contribution of Wt1-
expressing cells to the myocardium. Of note, this hypothetical contribution may originate 
from two sources, i) the EPDC and ii) migration of myocardial progenitors from the posterior 
secondary cardiac field, where Wt1 expression is prominent in mesenchymal cells of the 
transverse septum. Original evidence for Wt1-derived myocardial cells provided by Zhou et 
al. (62) was questioned by Rudat and Kispert (61) on the basis of the unsuitability of the Cre 
drivers used. Zhou and Pu (70) responded by providing new validating evidence for the 
existence of cardiomyocytes derived from Wt1-expressing cells, which they considered as 
epicardial-derived. On the other hand, the existence of a sinus venosus defect in Wt1-
deficient mouse embryos (8) could be interpreted as the lack of a Wt1 lineage population 
contributing to the inflow tract myocardium. This possibility was ruled out by Norden et al. 
(8) who, by using two different models (LacZ reporter and Wt1-Cre) found that Wt1-
expressing cells did not give rise to myocardial cells. These authors conclude that the 
involvement of the Wt1-lineage in sinus venosus development seems to be indirect.  
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Developmental haematopoiesis: 
Molecular evidence for Wt1 as a regulator of developmental haematopoiesis is based on 
studies showing that Wt1 regulates expression of both Epo and its receptor EpoR in the fetal 
liver as the primary haematopoietic organ during mid-gestation (57,58). Furthermore, loss 
of Wt1 affects in vitro differentiation of fetal liver cells, suggesting that Wt1 regulates 
possibly in synergy with EpoR the differentiation potential of fetal haematopoietic stem cells 
(57). However, transplantation studies into lethally irradiated mice showed that fetal liver-
derived Wt1-/- haematopoietic stem cells were as potent in restoring bone marrow and 
peripheral blood cells as wild type cells (71). 
 
Spleen: 
Wt1 is expressed in the spleen rudiment of the dorsal mesogastrium of mouse embryos by 
E10.5, continuing in the spleen capsule and epithelium by E14.5 (12). Herzer et al. (72) 
reported expression by E12.5 and described failure of spleen development in Wt1-/- 
embryos. Koehler et al. (73) found that the expression of Wt1 in the spleen follows that of 
Hox11 (a homeobox gene required for spleen development) with a delay of one day, while 
Hox11-/- embryos show reduced expression of Wt1 in the spleen rudiment, suggesting that 
Wt1 is acting downstream of Hox11 in spleen development.  
 
Body muscle: 
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Expression of Wt1 in musculature of the body wall of E12-E13 mice embryos was described 
by Armstrong et al. (2), but this observation has not been confirmed by further reports. It is 
possible that the presence of mesenchymal cells migrating from the dorsolateral coelomic 
epithelium to the lateral body wall is related with this early description.   
 
Nervous system and eye: 
Besides its extensive expression in mesodermal cells, there are only a few specific domains 
of Wt1 expression in the neuroectoderm. In mouse embryos, Wt1 is expressed from E11 in a 
narrow linear domain located between the mantle and the ependymal layers. This 
expression domain becomes more pronounced by E12 and expands by E13 before turning 
more diffuse, extending to the ventral part of the marginal area of the medulla and finally 
disappearing at the end of gestation (2, 12, 14). This expression is anatomically related to 
the area where motoneurons differentiate. A second area of expression is found in the roof 
of the 4th ventricle, in a diverticulum of the ependymal layer, close to the rostral part of the 
medulla oblongata (2, 12).  
Wt1 is also expressed in developing retina, as shown by RT-PCR in E12.5 mice embryos. In 
humans, retina expression of Wt1 has been detected in day 42 fetuses (2). Wt1 seems to be 
required for retinal development since Wt1-deficient mouse embryos show defects in 
retinal ganglion cells (74). This effect could be due to the activation of Pou4f2, a 
transcription factor essential for survival of retinal ganglion cells.  
 
Lung: 
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Wt1 is expressed in mesothelial cells of the murine lungs from the early sprouting of the 
lung buds onwards (6, 12, 75). Differently to the heart, Wt1 is rapidly down-regulated in 
cells delaminating from the mesothelium and incorporating into the pulmonary 
mesenchyme. These mesothelial-derived cells contribute to most pulmonary mesodermal 
tissues, including vascular and bronchial smooth muscle, tracheal cartilage and a small 
fraction of the vascular endothelium (6, 75). In neonates, about 1.5% of all the dissociated 
pulmonary cells and about 11% of all the endothelial cells derive from theWt1-expressing 
cell lineage (6). Another difference with the epicardium is that the migration of the 
mesothelial-derived cells inside the pulmonary stroma is dependent of hedgehog signaling 
(5).  
 
Liver: 
Wt1 is expressed in the liver mesothelium from of the early stages of hepatic development 
(2, 14). Liver mesothelial cells continue to express Wt1 when they migrate from the surface 
and intermingle with the hepatoblasts and the hematopoietic cells to differentiate into 
sinusoidal endothelium and stellate cells (14). In contrast to the heart and the lung, in the 
liver Wt1 is not down-regulated with onset of differentiation of mesothelium-derived cells. 
In fact, Wt1 expression is still detectable in sinusoidal endothelial cells (14). This invasion of 
mesothelial derived cells is necessary for proper hepatic development (76, 77).  
 
Adult expression of Wt1: 
Wt1 expression has been reported in a few sites of adult mice, namely kidney podocytes, 
Sertoli cells of the testes, granulosa cells of the ovary, mesothelia, pancreatic stellate cells, 
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the stromal vascular component of several fat bodies including visceral adipose tissue 
progenitors, and a small fraction of bone marrow cells (3, 78-80).  
The podocytes are the most prominent site of adult Wt1 expression, and in fact podocyte 
maintenance and function depends on Wt1 (80). In postnatal stages, Wt1 is involved in the 
regulation of the maintenance of the glomerular filtration function of the kidney, as shown 
through a range of studies. Mice with reduced Wt1 expression and subsequent 
downregulation of nephrin and podocalyxin expression showed increased 
glomerulosclerosis (26). The damage to the glomeruli is possibly caused by insufficient levels 
of podocalyxin and nephrin both of which are required for the functional morphology of the 
slit diaphragm and foot processes of the glomerular filtration membrane. Furthermore, 
recent study from the Ai lab has shown that Wt1 is important for maintaining cross-talk 
between podocytes and glomerular endothelial cells across glomerular filtration membrane. 
Specifically, Wt1 controls the expression of the 6-O-endosulfatases Sulf1 and Sulf2 which in 
turn regulate signalling of VEGFA from podocytes to glomerular endothelial cells across the 
glomerular filtration barrier (81).  
Wt1 expression is not maintained in all adult mesothelial tissues: while it is present in the 
adult intestine (3) and the mesothelium lining the visceral fat (78, 79), there are conflicting 
findings about Wt1 expression in the lung mesothelium, with Dixit and colleagues reporting 
downregulation of Wt1 in postnatal and adult mice, while Que and colleagues have shown 
continued expression in P45 animals (5, 79). Karki et al. (82) also stated that expression of 
Wt1 remains in the adult pulmonary mesothelium, and its loss is correlated with 
mesenchymalization and fibrosis. Wt1 expression in the liver mesothelium seems to be 
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downregulated after E13.5 (77). It is possible that a low basal level of Wt1 expression in 
adult mesothelium is the basis for these discrepancies. 
The expression of Wt1 in the visceral fat mesothelium and in the progenitors of the visceral 
white adipose tissue (WAT) establishes a key difference with other fat bodies such as 
subcutaneous WAT and brown adipose tissue that do not develop from Wt1-expressing cells 
(79). This difference could be significant given the different potential of visceral and 
subcutaneous WAT as risk factor for a number of diseases. 
Expression of Wt1 is maintained into adulthood in the Sertoli and granulosa cells (2, 10). 
Wt1 regulates Sertoli cell polarity in the testes, and it is essential for germ cell survival, 
differentiation and spermatogenesis (83, 84). Additionally, the expression of Wt1 in Sertoli 
cell is essential to maintain steroidogenesis in Leydig cells (85, 86). In the ovary, Wt1 is also 
expressed in granulosa cells, controlling their polarity and differentiation (87). In a mouse 
model mimicking the Denys-Drash Syndrome (DSS), heterozygous mice have reduced 
ovulation rates, premature differentiation of granulosa cells, leading to disturbed 
development of follicles (87). This study supports the notion that Wt1 is not only required 
for normal spermatogenesis, but also for oogenesis.  
Besides the ovary, Wt1 expression has also been reported in the embryonic and adult 
uterus, specifically the myometrium and human endometrium (10, 88, 89). 
Wt1 expression was detected in the bone marrow of mice and humans for the first time by 
Fraizer et al. (90). A range of studies showed that Wt1 expression in hematopoietic cells is 
restricted to the phase of expansion of hematopoietic progenitor cells while expression was 
found to be reduced in mature haematopoietic cells and absent in the mature peripheral 
blood (91, and references therein). Furthermore, it was found that Wt1 expression was 
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downregulated in haematopoietic cell lines that underwent differentiation, while high 
expression of Wt1 was correlated with induced proliferation of cells in culture (92, 93). Wt1 
seems to have conflicting roles in different stages of haematopoiesis since it can induce 
quiescence in early (CD34+ CD38-) progenitors, while it stimulates differentiative behaviour 
in more committed progenitor cells. Wt1 is present in erythroblastic progenitors, where it 
transactivates the EPO receptor (56). Wt1 is also involved in granulocyte differentiation (94). 
Single cell qPCR of cells during haematopoiesis revealed a biphasic expression pattern with 
high activity in quiescent primitive precursor cells and specific myeloid cell populations 
(95,96). Interestingly, using a genetically modified mouse line which expresses GFP under 
control of the endogenous Wt1 locus, Hosen and colleagues came to a slightly different 
finding, since in Wt1GFP/+ mice, Wt1 expression was absent or very low in haematopoietic 
stem cells or fully differentiated granulocytes, respectively, while expression was higher in 
myeloid progenitor cells (97). Loss of Wt1 in haematopoietic stem cells was shown to affect 
their differentiation potential (98). Furthermore, in an independent study using ES cells 
lacking Wt1 protein that were differentiated towards the haematopoietic lineage, similar 
observations were made, as the colony forming/differentiation potential of the cells was 
greatly reduced (99). The authors could show that Wt1-/- ES cells undergo apoptosis that is 
dependent of Vegfa, and that Wt1 is responsible for splicing of Vegfa into functional 
isoforms. The function of Wt1 in blood cell differentiation could be mediated by p21cip1 
induction, leading to growth arrest (95). This would explain the role played by Wt1 
mutations in leukemogenesis (see below). 
In some pathological conditions, the adult expression of Wt1 becomes more prominent. 
Wt1 is expressed in coronary arteries (endothelium and smooth muscle) after myocardial 
infarction (100). This is probably due to the hypoxia produced by the local ischemia, since 
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the upregulation of the Wt1 gene, mediated by a hypoxia responsive element in the Wt1 
promoter, is mimicked by exposing rats to hypoxic conditions (101). Thus, low oxygen 
tension could be a driver for Wt1-regulated angiogenesis (102). 
Wt1 was named after its supposed role in the development of Wilms' tumor (103), although 
only a fraction of these tumours shows alterations in WT1 expression. In contrast, abnormal 
overexpression of WT1 has been reported in a number of tumour cells (104), and it is 
particularly prominent in acute myeloid leukemia (AML) (105-107). WT1 is overexpressed in 
malignant cells of 90% of patients with AML and appears mutated in approximately 10% of 
these patients (108). Importantly, these observations have raised expectations for Wt1 as a 
target in cancer immunotherapy (109, 110).   
 
Wt1 expression in non-mammalian animal models: 
The developmental expression of Wt1 in chicken embryos is in principle similar to that 
described for mammals (111). Wt1 has been used as a marker of proepicardial, epicardial 
and epicardial-derived cells by a number of groups studying chick development (112-116).  
In zebrafish, two Wt1 genes, wt1a and wt1b, have been reported, both showing +KTS and -
KTS isoforms (117). In early embryos the expression of both genes is dynamic and restricted 
to intermediate mesoderm. Expression of wt1a in the zebrafish pronephros is regulated by 
retinoic acid through a highly conserved enhancer (118). In addition, wt1a has recently be 
reported to regulate expression of osr1, thus controlling the differentiation of zebrafish 
podocytes (119). The expression domains of wt1a and wt1b in adult fish tissues are more 
extensive than in mammals, including gonads, kidneys, heart, spleen and muscle. Both wt1a 
and wt1b, have also been reported in other fish, such as Oncorhynchus, Oryzias, Takifugu 
Wilm and Munoz-Chapuli 
19 
 
and Tetraodon (reviewed in 120). In Tetraodon, the highly conserved motif KTS, 
distinguishing DNA-binding to DNA non-binding isoforms, is changed to KPS (120).  
Information on Wt1 expression in amphibians is more limited. Wt1 is expressed in Sertoli 
cells, spermatogonia and mature sperm stages in the testes of the newt Cynops 
pyrrhogaster (121). In Xenopus, Wt1 expression is first restricted to the developing nephric 
system, and later is also detected in the developing heart (122, 123). Since Wt1 is not 
detected in developing pronephric tubules and ducts, its function seems to be related with 
the development of the glomeruli. In fact, when Wt1 was ectopically expressed in Xenopus 
embryos by mRNA injection, it inhibited pronephric tubule development (124).  
Regarding invertebrates, a Wt1 ortholog has been found in the cephalochordate 
Branchiostoma floridae (125). Furthermore, the Drosophila gene Klumpfuss has been 
considered as a Wt1 ortholog, and is involved in neuronal (126, 127) and hemocyte 
differentiation (128). However, despite the similarity between the four zinc-finger domains 
with those of the vertebrate Wt1, the N-terminal region is clearly different making this 
orthology very doubtful. 
Details of animal model systems and approaches to study systemic and inducible loss of 
function of Wt1 will be described in Chapter XYZ. 
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